Proof of Concept Study to Investigate Etokimab (ANB020) Activity in Adult Participants With Severe Eosinophilic Asthma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Randazzo, MD
AnaptysBio, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Medicines Evaluation Unit
Manchester, Greater Manchester, United Kingdom
- Glenfield Hospital
Leicester, Leicestershire, United Kingdom
- Churchill Hospital
Oxford, Oxfordshire, United Kingdom
- Midwest Allergy Sinus Asthma
Normal, Illinois, United States
- Pulmonary & Critical Care Specialists
Novi, Michigan, United States
- Ok Clinical Research, Llc
Edmond, Oklahoma, United States
- Allergy & Asthma Center of Southern Oregon
Medford, Oregon, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Nov 2017
- Primary completion
- 30 Oct 2018
- Completion
- 30 Oct 2018
- Last update posted
- 16 Aug 2023
- Registered enrollment
- 25
- Registry id
- NCT03469934
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.